Latest News

Hong Kong listings a target for foreign firms as IPOs rebound

?At least 10 companies, including those from Indonesia, South Korea, and Singapore, have applied for Hong Kong IPOs this year, and others are considering it, according to an executive at the Hong Kong Stock Exchange. The market's robust IPO growth is attracting global?firms.

LSEG data shows that although foreign companies raised a lot less money than domestic firms - 110 Chinese firms and Hong Kong firms raised a total of $36.4 billion in '2025 - the listings by 10 global companies would make this the best year since 2020 for international debuts. According to Johnson Chui, the head of global issuer service at Hong Kong Exchanges and Clearing Ltd. (HKEX), who runs the city’s stock exchange, foreign listing hopefuls come from sectors such as technology, consumer and financials.

He said that the pipeline is a mixture of first-time IPOs and concurrent dual listings as well as sequential dual listings.

Chui said, "We believe that this is a start of the structural change for the next phase of international companies listing in Hong Kong." He added the appeal of the City had expanded beyond companies with China-exposure.

He said, "The nexus has broadened." In the past, it was more about whether you had business in Greater China. There are now many successful companies who have no presence in this area of the world. According to LSEG 'data, the Hong Kong exchange was the top IPO market in the world last year, with $37.4bn raised through 115 deals. The bourse has been unable to attract large foreign listings, but it is now redoubling its efforts in an effort to increase the flow of foreign capital. Syngenta Group, a Swiss-based seeds, agrochemicals and chemicals company, plans to list up to $10 billion of shares in the second half this year. This move, according to sources reported in February, will likely boost HKEX’s ability to attract large-ticket listings.

Separate sources confirmed that while Chui didn't give any details on foreign IPO hopefuls he was aware of Engine Biosciences and NiKang Therapeutics, two international biotech companies from Singapore.

Sources familiar with plans of the two companies said that the discussions were preliminary and could change. The sources declined to be identified as the matter was confidential. Engine Biosciences refused to comment. NiKang did not respond.

PIPELINE IPO

Malaysian logistics company Teleport said it was considering Hong Kong as a venue for an IPO. "Our long-term plan includes a listing on the stock exchange," said CEO Pete Chareonwongsak. "We're keeping our options open."

Separately, LSEG's data compiled on 4 May showed that 12 foreign companies could be in Hong Kong’s 2026 IPO pipeline. These included U.S. Blockchain infrastructure firm Blockdaemon and Malaysian branding for logistics group Capital A.

HKEX announced that seven international companies will list in Hong Kong by 2025. According to LSEG, foreign companies have raised $22 billion in 156 transactions since 2000. This is a small fraction of the total market.

The current pipeline, unlike the previous wave of 15 years, which was led by consumer brands such as Prada, Samsonite and others, is more diverse in terms of sector, geography, and listing structure.

Citigroup's Asia Head of Equity Capital Markets Kenneth Chow stated that Hong Kong offers "the largest possible universe" for investors. This includes hedge funds, global?funds and Chinese institutions, as well as retail buyers.

George Wu, a partner at DLA Piper, said that mining companies were being drawn to the region because China is driving demand for strategic minerals. Clifford Chance Capital Markets partner Jean Thio stated that Hong Kong has built a system which rivals Nasdaq, in terms of listed companies, analyst coverage and comparable markets in industries like biotech and AI.

Chui, HKEX's Chui, said: "We believe Hong Kong is the best listing venue for international companies with an Asian connection."

(source: Reuters)